Back
Disc Medicine Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
35
IRON
Disc Medicine
Last Price:
$60.48
Seasonality Move:
-21.4%
Buy
53
ALNY
Alnylam Pharmaceuticals
Last Price:
$264.97
Seasonality Move:
-5.65%
Sell
35
Disc Medicine (IRON)
is a Sell
Is Disc Medicine a Buy, Sell or Hold?
-
The current Disc Medicine [IRON] share price is $60.52. The Score for IRON is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
IRON is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $264.99. The Score for ALNY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IRON Stock Price Chart
What is Disc Medicine's stock price today?
-
The Disc Medicine share price today is $60.52Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IRON is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $264.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
IRON Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.93 | Sell |
Relative Strength Index (14 RSI): | 47.35 | Sell |
Chaikin Money Flow: | 71959 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.17 - 64.85) | Sell |
Bollinger Bands (100): | (48.5 - 63.54) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.06 | Buy |
Relative Strength Index (14 RSI): | 61.89 | Buy |
Chaikin Money Flow: | 924287 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (235.22 - 250.1) | Buy |
Bollinger Bands (100): | (244.05 - 278.97) | Buy |
IRON Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.69 | Buy |
20-day SMA: | 61.94 | Sell |
50-day SMA: | 63.01 | Sell |
200-day SMA: | 47.39 | Buy |
8-day EMA: | 60.05 | Buy |
20-day EMA: | 61.3 | Sell |
50-day EMA: | 60.56 | Sell |
200-day EMA: | 53.14 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 248.59 | Buy |
20-day SMA: | 242.37 | Buy |
50-day SMA: | 248.91 | Buy |
200-day SMA: | 228.82 | Buy |
8-day EMA: | 249.65 | Buy |
20-day EMA: | 245.98 | Buy |
50-day EMA: | 249.85 | Buy |
200-day EMA: | 235.63 | Buy |
Disc Medicine Earnings Growth & IRON Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.12 per share, and a decrease next year of $0.10 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and an increase next year of $4.82 per share.
Disc Medicine Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |